Technical Analysis for IVA - Inventiva S.A.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 3.44 | -0.29% | -0.01 |
IVA closed down 0.29 percent on Wednesday, May 8, 2024, on 3 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: May 29
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -0.29% | |
| Inside Day | Range Contraction | -0.29% | |
| Gapped Up | Strength | -0.29% | |
| Up 3 Days in a Row | Strength | -0.29% | |
| 50 DMA Resistance | Bearish | 0.29% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.29% | |
| Crossed Above 20 DMA | Bullish | 0.29% |
| Alert | Time |
|---|---|
| Possible NR7 | about 16 hours ago |
| Possible Inside Day | about 16 hours ago |
| 60 Minute Opening Range Breakout | about 17 hours ago |
| Down 1% | about 21 hours ago |
| Gap Up Closed | 1 day ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/29/2024
Inventiva SA engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centred on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Frédéric Cren on October 27, 2011 and is headquartered in Daix, France.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Alcohol Genetics Gene Expression Hepatitis Steatohepatitis Non Alcoholic Fatty Liver Disease DNA Fibrosis Small Molecule Therapies Transcription Transcription Factors Epigenetics Transcription Factor Hepatitis A
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Alcohol Genetics Gene Expression Hepatitis Steatohepatitis Non Alcoholic Fatty Liver Disease DNA Fibrosis Small Molecule Therapies Transcription Transcription Factors Epigenetics Transcription Factor Hepatitis A
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 5.04 |
| 52 Week Low | 2.4577 |
| Average Volume | 42,202 |
| 200-Day Moving Average | 3.86 |
| 50-Day Moving Average | 3.61 |
| 20-Day Moving Average | 3.32 |
| 10-Day Moving Average | 3.28 |
| Average True Range | 0.20 |
| RSI (14) | 50.74 |
| ADX | 15.51 |
| +DI | 28.10 |
| -DI | 14.82 |
| Chandelier Exit (Long, 3 ATRs) | 3.38 |
| Chandelier Exit (Short, 3 ATRs) | 3.65 |
| Upper Bollinger Bands | 3.60 |
| Lower Bollinger Band | 3.04 |
| Percent B (%b) | 0.71 |
| BandWidth | 16.98 |
| MACD Line | -0.07 |
| MACD Signal Line | -0.11 |
| MACD Histogram | 0.0377 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.49 | ||||
| Resistance 3 (R3) | 3.48 | 3.46 | 3.48 | ||
| Resistance 2 (R2) | 3.46 | 3.45 | 3.46 | 3.47 | |
| Resistance 1 (R1) | 3.45 | 3.44 | 3.46 | 3.46 | 3.47 |
| Pivot Point | 3.43 | 3.43 | 3.43 | 3.43 | 3.43 |
| Support 1 (S1) | 3.42 | 3.42 | 3.43 | 3.43 | 3.41 |
| Support 2 (S2) | 3.40 | 3.41 | 3.40 | 3.41 | |
| Support 3 (S3) | 3.39 | 3.40 | 3.40 | ||
| Support 4 (S4) | 3.40 |
